Aptevo Therapeutics
APVO
1 hedge funds and large institutions have $89.7M invested in Aptevo Therapeutics in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0% → 0% (0%)
16% less capital invested
Capital invested by funds: $107M → $89.7M (-$17M)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$301K |
| 2 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$235K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$231K |
| 4 |
Millennium Management
New York
|
-$228K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$202K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| $34K | – | – | – |
|
|
TRSOTSOK
27
Teachers Retirement System of the State of Kentucky
Frankfort,
Kentucky
| $12K | – | – | – |
|
28
Fifth Third Bancorp
Cincinnati,
Ohio
| $9K | – | – | – |
|
29
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $4K | – | – | – |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| $4K | – | – | – |
|
|
TC
31
Truvestments Capital
Sarasota,
Florida
| $4K | – | – | – |
|
|
SFS
32
Sowell Financial Services
North Little Rock,
Arkansas
| $1K | – | – | – |
|
33
Acadian Asset Management
Boston,
Massachusetts
| – | -$113K | – | – |
|
34
Citigroup
New York
| – | -$35K | – | – |
|
|
35
Dimensional Fund Advisors
Austin,
Texas
| – | -$202K | – | – |
|
|
36
Millennium Management
New York
| – | -$228K | – | – |
|
|
PVI
37
Pura Vida Investments
New York
| – | -$301K | – | – |
|
|
SFI
38
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
| – | -$235K | – | – |
|
|
39
T. Rowe Price Associates
Baltimore,
Maryland
| – | -$231K | – | – |
|
40
UBS Group
Zurich,
Switzerland
| – | -$11K | – | – |
|
APVO Hedge Fund Activity: Q1 2021 in Review
1 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Aptevo Therapeutics (APVO) for Q1 2021, worth a combined $89.7M — down 16% from $107M a quarter earlier.
Fund positioning in APVO was balanced in Q1 2021: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
The largest seller was Pura Vida Investments, cutting an estimated $301K.
- 1 institutional investor held Aptevo Therapeutics (APVO) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $89.7M of Aptevo Therapeutics stock for Q1 2021, down 16% quarter-over-quarter.
- 0 funds opened new Aptevo Therapeutics positions in Q1 2021 and 0 closed out.
- The largest Aptevo Therapeutics seller in Q1 2021 was Pura Vida Investments, an estimated $301K sold.
Based on aggregated 13F filings for Q1 2021.